The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand...
Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability...
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging...
Rare Diseases – An Evolving Medical Communications Landscape
A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
Leveraging Social Media to Transform Medical Affairs
This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...